Share
Journal Information
Most often read
583
“Methodological notes”: a new and important section in Clínica e Investigación en ArteriosclerosisJosep Ribalta, Carlos Lahoz, Xavier Pintó
Clin Investig Arterioscler. 2023;35:243
583
Full text access
Open Article
456
Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primerMaría A. Zuriaga, José J. Fuster
Clin Investig Arterioscler. 2023;35:35-41
456
Open Article
438
Dietary modulation of advanced glycation end products metabolism on carotid intima-media thickness in type 2 diabetes patients: From the CORDIOPREV studyElena M. Yubero-Serrano, Francisco M. Gutiérrez-Mariscal, Purificación Gómez-Luna, Juan F. Alcalá-Diaz, Pablo Pérez-Martinez, José López-Miranda
Clin Investig Arterioscler. 2023;35:105-14
438
Open Article
420
Absence of the influence of the APOE gene on the incidence of type 2 diabetes mellitus in a cohort of workers: Effect of diet and shift workRocío Mateo-Gallego, Sofía Pérez-Calahorra, Ana M. Bea, Irene Gracia-Rubio, Carmen Rodrigo-Carbo, Belen Moreno-Franco, Fernando Civeira, Martín Laclaustra, Itziar Lamiquiz-Moneo
Clin Investig Arterioscler. 2023;35:226-35
420
Open Article
384
Prevalence rates of chronic kidney disease and its association with cardiometabolic factors and cardiovascular diseases. SIMETAP-CKD studyAntonio Ruiz-Garcia, Ezequiel Arranz-Martínez, Nerea Iturmendi-Martínez, Teresa Fernández-Vicente, Montserrat Rivera-Teijido, Juan Carlos García-Álvarez
Clin Investig Arterioscler. 2023;35:64-74
384
Open Article
370
Pemafibrate: PROMINENT failure or an urgent need for therapeutic replacement?Juan Carlos Laguna Egea, Núria Roglans Ribas, Roger Bentanachs Raset
Clin Investig Arterioscler. 2023;35:202-5
370
Full text access
Open Article
358
Vascular smooth muscle cell aging: Insights from Hutchinson-Gilford progeria syndromeMagda R. Hamczyk, Rosa M. Nevado
Clin Investig Arterioscler. 2023;35:42-51
358
Open Article
291
Remnant cholesterol, vascular risk, and prevention of atherosclerosisXavier Pintó, Marta Fanlo, Virginia Esteve, Jesús Millán
Clin Investig Arterioscler. 2023;35:206-17
291
Open Article
287
Health-related lifestyle assessment among Spanish adults from 22 to 72 yearsPedro Luis Rodríguez García, Juan José Pérez Soto, Eliseo García Cantó, Marcos Meseguer Zafra, Raúl Salmerón Ríos, Pedro Juan Tárraga López
Clin Investig Arterioscler. 2023;35:12-20
287
Open Article
278
Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptorSusana Martín-Vañó, Alejandra Miralles-Abella, Pascual Castaño, Gema Hurtado-Genovés, María Aguilar-Ballester, Andrea Herrero-Cervera, Angela Vinué, Sergio Martínez-Hervás, Herminia González-Navarro
Clin Investig Arterioscler. 2023;35:1-11
278
Full text access
Open Article
273
Arterial ageing and atherosclerotic risk: new perspectivesVicente Lahera Juliá, Ana M. Lahera García
Clin Investig Arterioscler. 2023;35:32-4
273
Open Article
260
The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysisJose A. Quesada, Vicente Bertomeu-González, Domingo Orozco-Beltrán, Alberto Cordero, Vicente F. Gil-Guillén, Adriana López-Pineda, Rauf Nouni-García, Concepción Carratalá-Munuera
Clin Investig Arterioscler. 2023;35:165-77
260
Open Article
257
A case of hypocholesterolemia under researchAna Camacho, María José Ariza, Nuria Amigó, Patricia Macías Guillén, Miguel Ángel Sánchez Chaparro, Pedro Valdivielso
Clin Investig Arterioscler. 2023;35:244-7
257
Full text access
Open Article
248
Observational study of patients from a Lipid Unit on lipid-modifying therapy for primary and secondary prevention: ULFI StudyÀlex Vila, Estel Pons, Patricia Trinidad García, Daniel Vidal, Sara López, Armand Grau
Clin Investig Arterioscler. 2023;35:272-9
248
Full text access
Open Article
220
Association of rs662799 and rs5070 genetic polymorphisms with hypertriglyceridemia and atherogenic dyslipidemia in pediatric patients in Southeast MexicoValeria Ovando Gómez, Soraya Amalí Zavaleta Muñiz, Héctor Ochoa-Díaz-López, José Armando Camilo Hernández Contreras, Cesar Antonio Irecta Nájera
Clin Investig Arterioscler. 2023;35:53-63
220
Open Article
220
Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS studyAgustín Blanco Echevarría, Juan De Dios García Díaz, Assumpta Caixas, Núria Plana Gil, Miguel Ángel Rico Corral, Ian Bridges, Nafeesa Dhalwani, Sònia Gatell Menchen, Kausik K. Ray
Clin Investig Arterioscler. 2023;35:263-71
220
Full text access
Open Article
211
Consensus document for lipid profile determination and reporting in Spanish clinical laboratoriesTeresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruiz, Manuel Rodríguez Piñero, José Francisco Valderrama Marcos, Antonio Pérez Pérez, Manuel Antonio Botana López, Ana Morais López, ... en representación del Grupo Multidisciplinar de Trabajo de Lípidos y Riesgo Vascular
Clin Investig Arterioscler. 2023;35:91-100
211
Full text access
Open Article
199
Geostatistical analysis from the clinical laboratory in cardiovascular prevention for primary careSalomón Martín Pérez, Teresa Arrobas Velilla, Juan Fabiani de la Iglesia, Ignacio Vázquez Rico, Gema Varo Sánchez, Antonio León-Justel
Clin Investig Arterioscler. 2023;35:75-84
199
Open Article
187
Nutritional recommendations in the prevention and treatment of atherogenic dyslipidemiaVicente Pascual, José Luis Díaz, Jesús Millán Nuñez-Cortés, Pablo Pérez-Martínez
Clin Investig Arterioscler. 2023;35:155-63
187
Open Article
185
Cardiovascular risk factors and death in South AmericaPatricio López-Jaramillo, José P. López-López
Clin Investig Arterioscler. 2023;35:195-200
185
Open Article